• Home
  • Criteria
  • Team
  • News
  • Filings
  • Contact
  • More
    • Home
    • Criteria
    • Team
    • News
    • Filings
    • Contact
  • Home
  • Criteria
  • Team
  • News
  • Filings
  • Contact

Seeking Category-Defining Businesses in High-Growth Markets

Seeking Category-Defining Businesses in High-Growth MarketsSeeking Category-Defining Businesses in High-Growth MarketsSeeking Category-Defining Businesses in High-Growth Markets

Experienced investors. Proven operators. Public market expertise.

Cambridge Acquisition Corp. (NASDAQ: CAQ) is a special purpose acquisition company seeking businesses positioned to benefit from regulatory, technological and consumer-driven market shifts.


Our team combines private equity, venture capital, operational leadership, and public market experience to identify and support category-defining businesses.

Investment Criteria

Clear and Defensible Competitive Advantages

High Growth Potential and Strong Unit Economics

High Growth Potential and Strong Unit Economics

Businesses with differentiated products, services or intellectual property that create barriers to entry and sustainable market leadership.

High Growth Potential and Strong Unit Economics

High Growth Potential and Strong Unit Economics

High Growth Potential and Strong Unit Economics

Companies positioned to capture significant market share in expanding sectors, with scalable business models and attractive margins.

Experienced and Visionary Management Teams

High Growth Potential and Strong Unit Economics

Attractive Valuation Relative to Growth Prospects

Leadership with a demonstrated ability to execute, adapt, and innovate, and who can benefit from our strategic, operational and capital markets expertise.

Attractive Valuation Relative to Growth Prospects

Attractive Valuation Relative to Growth Prospects

Attractive Valuation Relative to Growth Prospects

Opportunities where our due diligence shows compelling value compared to public and private market peers.

Benefit from Public Company Status

Attractive Valuation Relative to Growth Prospects

Benefit from Public Company Status

Targets that can leverage public market access for growth capital, acquisition currency and enhanced brand credibility.

Leadership Team

Michael Cam-Phung - Chairman

 

  • Former Chief Strategy Officer at Seisa Medical, leading M&A and exit to strategic at ~$300M sale in 2023
  • Advisor to Bail Capital and its predecessor organization Bailey Capital Management since 2016
  • 9 years in private equity and growth equity at Highland Consumer
  • Began his finance career at BMO’s Debt Capital Markets group before transitioning to Consumer & Retail coverage at William Blair

Brent Cox - Director & CEO

 

  • Founder of Subtext Holdings and The Inception Companies; early investor in MedMen, Bombas, Sunday Goods, Thrive Market, Weedmaps, Terzo, Lob, Loft, Saucey, CleanCore Solutions, Coupang, Sir Kensington’s and Juul 
  • Private equity experience at Yucaipa Companies across LBOs, rollups, and turnarounds: Soho House, Americold / Versacold, and Ei

 

  • Founder of Subtext Holdings and The Inception Companies; early investor in MedMen, Bombas, Sunday Goods, Thrive Market, Weedmaps, Terzo, Lob, Loft, Saucey, CleanCore Solutions, Coupang, Sir Kensington’s and Juul 
  • Private equity experience at Yucaipa Companies across LBOs, rollups, and turnarounds: Soho House, Americold / Versacold, and Eimskip
  • Began finance career at Jefferies in Leveraged Finance / Financial Sponsors

Tony Naimo - CFO

 

  • Founder and Managing Director of Procorso, advising consumer brands and investors
  • 15+ years of financial leadership in luxury consumer across venture, PE and public companies
  • Former roles at Estée Lauder, Aesop (NA lead), Opening Ceremony (CFO); currently CFO of Sarah Flint

Christopher Bradley - Independent Director

Christopher Bradley is a Managing Director at Mistral Equity Partners with two decades of experience in acquisitions and SPAC leadership. He has led or supported public combinations including OneSpaWorld, ARKO, Biote, and Suncrete, and holds board roles at Insomnia Cookies and multiple SPACs and private funds. Prior roles include investme

Christopher Bradley is a Managing Director at Mistral Equity Partners with two decades of experience in acquisitions and SPAC leadership. He has led or supported public combinations including OneSpaWorld, ARKO, Biote, and Suncrete, and holds board roles at Insomnia Cookies and multiple SPACs and private funds. Prior roles include investment banking at Bank of America and strategy at Burger King and PwC.

Vanessa Rollings Giannis - Independent Director

Vanessa Rollings Giannis - Independent Director

Vanessa Giannis is the founder of Convivium Advisors and a former CFO at Big Health and Tempus AI. With nearly 30 years of financial leadership experience, she has held senior roles across tech, health, and media companies. She holds degrees from the University of Notre Dame and Northwestern’s Kellogg School.


Eric Sklar - Independent Director

Vanessa Rollings Giannis - Independent Director

Eric Sklar is the founder and CEO of Napa Valley Fume and a longtime consumer packaged goods entrepreneur. He also serves as a Commissioner on the California Fish & Game Commission. His past ventures include founding and managing Burrito Brothers, Alpha Omega Winery, Yount Ridge Cellars, and Preslar Ventures. He previously served as both 

Eric Sklar is the founder and CEO of Napa Valley Fume and a longtime consumer packaged goods entrepreneur. He also serves as a Commissioner on the California Fish & Game Commission. His past ventures include founding and managing Burrito Brothers, Alpha Omega Winery, Yount Ridge Cellars, and Preslar Ventures. He previously served as both a Planning Commissioner and City Council Member in St. Helena, California. He holds a BA from UC Berkeley and graduate business degrees from The London School of Economics and Georgetown University.


Why Cambridge Acquisition Corp?

Proven Track Record in Stigmatized and Under-Served Markets

Deep Sector Expertise Across Multiple High-Growth Categories

Deep Sector Expertise Across Multiple High-Growth Categories

Our principals have delivered significant returns over a decade by backing category leaders (by market share) in sectors overlooked or avoided by mainstream capital. Notable investments include JUUL, Compass Pathways, MindMed, Beckley Psytech and Mindbloom, each of which achieved significant value creation and, in several cases, public market listings.

Deep Sector Expertise Across Multiple High-Growth Categories

Deep Sector Expertise Across Multiple High-Growth Categories

Deep Sector Expertise Across Multiple High-Growth Categories

We have experience in nicotine harm reduction, hemp-derived consumables, psychedelics, functional botanicals, gaming, the love economy and health-oriented markets. This ability includes navigating complex regulatory environments and anticipating inflection points in public perception and policy.

Extensive Founder and Operator Network

Deep Sector Expertise Across Multiple High-Growth Categories

Operational and Transactional Excellence

Our team has co-founded, seeded or been the first institutional investor in numerous category-defining companies. These relationships provide us with proprietary deal flow and the ability to engage with high-caliber management teams early in their growth trajectory.

Operational and Transactional Excellence

Operational and Transactional Excellence

Operational and Transactional Excellence

Collectively, our principals have executed dozens of transactions, including mergers, acquisitions, roll-ups and public offerings. We bring institutional rigor to strategy development, capital allocation, and governance.

Prior SPAC and Public Market Experience

Operational and Transactional Excellence

Prior SPAC and Public Market Experience

Members of our team have successfully raised substantial capital and guided companies through the transition to public markets. Additionally, Christopher Bradley, one of our director nominees, formed part of the leadership team that has consummated numerous SPAC business combinations.

Disciplined Investment Approach

Operational and Transactional Excellence

Prior SPAC and Public Market Experience

We apply rigorous due diligence, sector expertise and institutional investment discipline to identify businesses aligned with our acquisition strategy.

In The News

CAC Announces the Separate Trading of its Class A Ordinary Shares and Warrants - March 30, 2026CAC Announces Closing of $230 Million Initial Public Offering - february 9, 2026CAC Announces the Pricing of $200 Million Initial Public Offering - february 6, 2026

SEC Filings

View sec filings

Contact Us

Please complete the form below

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cambridge Acquisition Corp.

One Liberty Square, 13th FL

Boston, MA 02109

(617) 396 4911



Forward Looking Statements

This website contains “forward-looking statements.” Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include statements regarding business plans, objectives, expectations and intentions of Cambridge Acquisition Corp. (the “Company”). These statements are based on current expectations and beliefs, as well as a number of assumptions concerning future events. Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside the Company’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and, unless required by law, the Company undertakes no obligation to update or revise the forward looking statements, whether as a result of new information, future events or otherwise.  

No Offer or Solicitation

The information on this website shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities or in respect of the proposed transaction. The information on this website shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of section 10 of the Securities Act of 1933, as amended.

© 2026 CAMBRIDGE ACQUISITION CORP. ALL RIGHTS RESERVED.

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept